Date: 2013-08-28
Type of information: Company acquisition
Acquired company: Peptisyntha (Belgium)
Acquiring company: International Chemical Investors Group (ICIG) (Germany)
Amount:
Terms: * On August 28, 2013, International Chemical Investors Group (ICIG) and the Solvay Group have entered into an agreement under which ICIG will acquire Peptisyntha SA, Belgium, based custom manufacturer of peptides for pharmaceutical use. Upon closing of the deal, Peptisyntha will become a member of ICIG’s CordenPharma platform as its third site offering peptides manufacturing.As a CordenPharma member company, Peptisyntha will continue to execute its growth strategy, serving a wide range of applications and customers. While the US sister company Peptisyntha Inc., Torrance, California, is not part of the transaction, certain of its customer relationships will be assumed by Peptisyntha in Brussels.
Details: For Solvay, the divestiture marks another step in focusing on its core industrial activities, and completes the group’s exit from life science activities.
Related: peptides
API
production
